Molecular hydrogen therapies and the benefits for menopausal and perimenopausal women: An aphoristic review

Abstract

Women account for half of the global population, yet, when applying of the principles of legislation to women's health and gender-based research there is a void pertaining to women-specific healthcare as they age. Hydrogen therapies such as oxy-hydrogen (HHO, H2/O2) inhalation act as a novel, non-toxic, antioxidant and anti-inflammatory compounds, with clinical and empirical research confidently suggesting such therapies may be beneficial to human reproductive health. This aphoristic review highlights the need for medical evidence-based research into female-focused age conditioning and offers an explanation as to why HHO therapies may be effective in combatting menopausal and perimenopausal symptoms.

Study details

Article type

Hypothesis

Outcome

Mixed

Findings

Through modulation of the redox environment (via direct and indirect mechanisms), attenuating aberrant immunological responses, and the inherent safety of H2 as a biocompatible compound, it is evidential that hydrogen regimens are likely to be highly beneficial as an adjunctive, or an alternative, to prevalent therapeutic strategies for women experiencing exuberant symptoms of climacteric transition